Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study

Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease (COVID-19) has spread pandemically with high rates of morbidity and mortality. COVID-19 has also posed unprecedented challenges in terms of rapid development of pharmacological countermeasures to prevent or contrast SARS-Co...

Full description

Bibliographic Details
Main Authors: Giuseppe A. Ramirez, Maria Gerosa, Chiara Bellocchi, Daniel Arroyo-Sánchez, Chiara Asperti, Lorenza M. Argolini, Gabriele Gallina, Martina Cornalba, Isabella Scotti, Ilaria Suardi, Luca Moroni, Lorenzo Beretta, Enrica P. Bozzolo, Roberto Caporali, Lorenzo Dagna
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomolecules
Subjects:
systemic lupus erythematosus
COVID-19
SARS-CoV-2
antivirals
monoclonal antibodies
Online Access:https://www.mdpi.com/2218-273X/13/9/1273

Internet

https://www.mdpi.com/2218-273X/13/9/1273

Similar Items